Tests repetitive magnetic brain stimulation for negative symptoms of schizophrenia
Tests magnetic brain stimulation on negative symptoms in adults with schizophrenia.
Plain-language title generated from the registry record
Registry title: Treatment of Negative Symptoms of Schizophrenia by rTMS
Key facts
- Where
- Neuilly-sur-Marne, FranceSee the site
Where in France
- Etablissement Public de Santé de Ville-EvrardNeuilly-sur-Marne, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre hospitalier de Ville-Evrard, France
- Trial code
- NCT06595654
- Record updated
- 19 September 2024
- Original description
The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions. It will also provide a regulatory framework to rTMS treatments under these conditions. 4 types of rTMS protocols are proposed, allowing to adapt to patients and their tolerances.Treatment lasts between 2 and 4 weeks, with a follow-up period of 3 months after treatment to observe relapses.To assess the evolution of negative symptoms between baseline and the end of treatment, investigators use SANS (Scale for the Assessment of Negative Symptoms).Read full original descriptionShow less
Treatment of Negative Symptoms of Schizophrenia by Repetitive Transcranial Magnetic Stimulation: A Naturalistic Study
The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions. It will also provide a regulatory framework to rTMS treatments under these conditions. 4 types of rTMS protocols are proposed, allowing to adapt to patients and their tolerances.Treatment lasts between 2 and 4 weeks, with a follow-up period of 3 months after treatment to observe relapses.To assess the evolution of negative symptoms between baseline and the end of treatment, investigators use SANS (Scale for the Assessment of Negative Symptoms).
Inclusion: Patient over 18 years of age; Patient diagnosed with schizophrenia according to the DSM-V criteria (Diagnostic and Statistical Manual of Mental Disorder V5, 2013); Stable drug treatment for at least 4 weeks; Presence or persistence of negative symptoms in the foreground:; Negative PANSS score ⩾21, positive PANSS score ⩽24; Patient (or legal representative) willing to participate in the study and having signed an informed consent; Patient fluent in the French language; Affiliation to a social security scheme.
Exclusion: Present a contraindication to TMS: intracranial foreign body, unstabilized epilepsy, cochlear implant, pace-maker; Presence of an unstabilized medical condition; Pregnant woman; Woman of childbearing potential and without effective contraception; Breastfeeding woman.